ChromaDex (CDXC) Competitor Comparison
We are evaluating the key criteria listed to compare ChromaDex (CDXC) against its competitors in the Biotechnology industry.
Market Capitalization
248 / 368Gross Profits
67 / 278Total Revenue
96 / 300EBITDA
41 / 337Free Cashflow
31 / 352Quick Ratio
305 / 357Earnings per Share
43 / 359Dividend yield
0 / 6Total Cash
291 / 358Performance 3 years
91 / 368Performance 5 years
70 / 368Performance 10 years
71 / 368Linearity 3 years
25 / 368Linearity 5 years
292 / 368Linearity 10 years
212 / 368Total Rank
86 / 368Dividend Rank
89 / 368Valuation Rank
107 / 368Piotroski Rank
195 / 368Muliplier Rank
85 / 368Total Cash - CDXC ranking 291 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.